RECOMBINANT EXPRESSION VECTORS FOR ENCAPSULIN-BASED VACCINE PRODUCTION AND METHODS FOR THEM.
VN10060840BActive Publication Date: 2026-09-03INTHERA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- VN1202208658
- Authority / Receiving Office
- VN · VN
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-05-31
- Publication Date
- 2026-09-03
- Estimated Expiration
- 2041-05-31
Abstract
The invention relates to an encapsulin protein and a fusion protein comprising this protein, and specifically to a recombinant expression vector for vaccine production, and a method for producing a vector strain containing the polynucleotide encoding the target protein, the encapsulin protein, and the interaction domain RNA (RLD) protein, to improve the expression efficiency of the target protein, and thus enable the production of a highly effective water-soluble vaccine using a large amount of the target protein. Furthermore, the invention relates to a method for producing this vaccine.
Need to check novelty before this filing date? Find Prior Art